This story was first published in digitalhealth.net
Cancer Research UK, LifeArc and Ono form cancer immunotherapy alliance
New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance between Cancer Research UK, LifeArc and Ono Pharmaceutical Co., Ltd.
The collaboration will identify targets for the development of both antibody and small molecule therapeutics. Funded by investment from Ono and LifeArc, drug discovery experts will be pursuing targets within Cancer Research UK’s portfolio of immuno-oncology research.
Under the terms of the deal, LifeArc will progress antibody projects via its antibody screening and development expertise. Small molecule projects will be taken forward by Cancer Research UK’s Therapeutic Discovery Labs.
Dr Hamish Ryder, director of Cancer Research UK's Therapeutic Discovery Labs, said:
"This unique alliance is a melting pot of world-leading cancer research and each organisation’s extensive expertise in oncology drug discovery" - Dr Hamish Ryder, director of Cancer Research UK's Therapeutic Discovery Labs
Ono will have option rights to licence the outputs of the alliance, and take on clinical development and commercialisation of successful projects with worldwide exclusive rights. Cancer Research UK and LifeArc will receive an upfront access fee for entering the alliance, as well as additional upfront, milestone, and royalty payments for licensed projects.
Dr Hamish Ryder continued: “We’re thrilled to welcome Ono to join and expand our successful collaboration with LifeArc and create one of our most ambitious alliances to date.
“As we enter into a new age of immuno-therapeutic approaches to cancer care, we hope that this partnership will accelerate the development of new treatments, bringing them to patients with cancer much faster.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
